🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/09/1995 | 36,03 | 36,49 | 35,56 | 36,49 | +2,63% | 2,60% | 59.364 |
| 20/09/1995 | 36,49 | 36,49 | 35,09 | 35,56 | -2,56% | 3,85% | 8.202 |
| 19/09/1995 | 36,49 | 36,49 | 35,09 | 36,49 | +0,00% | 3,85% | 6.118 |
| 18/09/1995 | 36,03 | 36,49 | 35,09 | 36,49 | +4,00% | 3,90% | 26.049 |
| 15/09/1995 | 36,49 | 36,49 | 35,09 | 35,09 | -2,60% | 3,85% | 11.675 |
| 14/09/1995 | 36,49 | 36,49 | 35,09 | 36,03 | -1,28% | 3,85% | 22.041 |
| 13/09/1995 | 35,09 | 36,49 | 35,09 | 36,49 | +1,30% | 4,00% | 60.834 |
| 12/09/1995 | 36,49 | 36,49 | 35,09 | 36,03 | -1,28% | 3,85% | 46.995 |
| 11/09/1995 | 36,49 | 36,49 | 35,09 | 36,49 | +0,00% | 3,85% | 27.572 |
| 08/09/1995 | 33,69 | 36,49 | 33,69 | 36,49 | +8,33% | 8,33% | 97.569 |
| 07/09/1995 | 34,62 | 34,62 | 33,69 | 33,69 | -2,70% | 2,70% | 9.431 |
| 06/09/1995 | 34,62 | 34,62 | 33,22 | 34,62 | +1,37% | 4,05% | 4.515 |
| 05/09/1995 | 33,69 | 35,09 | 33,69 | 34,15 | +0,00% | 4,17% | 22.389 |
| 01/09/1995 | 33,69 | 35,09 | 33,69 | 34,15 | -1,35% | 4,17% | 13.011 |
| 31/08/1995 | 33,22 | 35,09 | 33,22 | 34,62 | +2,78% | 5,63% | 9.057 |
| 30/08/1995 | 33,69 | 34,62 | 33,22 | 33,69 | +1,41% | 4,17% | 5.236 |
| 29/08/1995 | 36,96 | 36,96 | 33,22 | 33,22 | -7,79% | 10,13% | 53.994 |
| 28/08/1995 | 36,96 | 36,96 | 35,56 | 36,03 | +0,00% | 3,80% | 10.393 |
| 25/08/1995 | 36,03 | 36,96 | 36,03 | 36,03 | -2,53% | 2,60% | 23.297 |
| 24/08/1995 | 36,49 | 36,96 | 35,56 | 36,96 | +3,95% | 3,85% | 30.163 |
| 23/08/1995 | 36,96 | 36,96 | 35,56 | 35,56 | +1,33% | 3,80% | 12.851 |
| 22/08/1995 | 35,56 | 36,96 | 34,62 | 35,09 | -3,85% | 6,58% | 13.599 |
| 21/08/1995 | 35,56 | 36,96 | 35,56 | 36,49 | -1,27% | 3,95% | 7.160 |
| 18/08/1995 | 36,96 | 36,96 | 35,56 | 36,96 | +1,28% | 3,80% | 22.896 |
| 17/08/1995 | 36,03 | 36,96 | 35,09 | 36,49 | +1,30% | 5,19% | 24.366 |
| 16/08/1995 | 36,49 | 36,49 | 34,62 | 36,03 | +1,32% | 5,13% | 64.173 |
| 15/08/1995 | 37,90 | 38,37 | 35,56 | 35,56 | -5,00% | 7,41% | 54.288 |
| 14/08/1995 | 35,09 | 37,43 | 35,09 | 37,43 | +3,90% | 6,67% | 44.590 |
| 11/08/1995 | 35,09 | 36,03 | 34,15 | 36,03 | +2,67% | 5,33% | 103.874 |
| 10/08/1995 | 35,09 | 36,03 | 35,09 | 35,09 | +1,35% | 2,67% | 200.348 |